DYADIC INTERNATIONAL INC Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
DYADIC INTERNATIONAL INC (DYAI) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 5.45 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-12
- DYADIC INTERNATIONAL INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 5.45M shares, a 10.17% decline year-over-year.
- DYADIC INTERNATIONAL INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 6.13M shares, a 4.28% decline year-over-year.
- DYADIC INTERNATIONAL INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 6.30M shares, a 5.64% increase year-over-year.
- DYADIC INTERNATIONAL INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 6.06M shares.
- DYADIC INTERNATIONAL INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 5.36M shares, a 7.36% decline from fiscal 2024.
- DYADIC INTERNATIONAL INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 5.79M shares.
- DYADIC INTERNATIONAL INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 5.03M shares, a 5.38% increase from fiscal 2021.
- DYADIC INTERNATIONAL INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 4.77M shares, a 2.93% increase from fiscal 2020.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 5.45M shares 10-Q · filed 2026-08-12 | 5.45M shares 10-Q · filed 2026-08-12 | |||||
| 2026-03-31 | 6.13M shares 10-Q · filed 2026-05-13 | ||||||
| 2025-12-31 | 5.36M shares 10-K · filed 2026-03-25 | ||||||
| 2025-09-30 | 6.30M shares 10-Q · filed 2025-11-12 | 6.30M shares 10-Q · filed 2025-11-12 | |||||
| 2025-06-30 | 6.06M shares 10-Q · filed 2026-08-12 | 6.06M shares 10-Q · filed 2026-08-12 | |||||
| 2025-03-31 | 6.40M shares 10-Q · filed 2026-05-13 | 6.06M shares 10-Q · filed 2025-08-13 | |||||
| 2024-12-31 | 5.79M shares 10-K · filed 2026-03-25 | ||||||
| 2024-09-30 | 5.96M shares 10-Q · filed 2025-11-12 | 5.96M shares 10-Q · filed 2025-11-12 | |||||
| 2024-06-30 | 5.95M shares 10-Q · filed 2025-08-13 | ||||||
| 2024-03-31 | 5.95M shares 10-Q · filed 2025-08-13 | ||||||
| 2023-09-30 | 5.28M shares 10-Q · filed 2023-11-08 | 5.28M shares 10-Q · filed 2023-11-08 | |||||
| 2023-06-30 | 5.03M shares 10-Q · filed 2023-08-09 | ||||||
| 2023-03-31 | 5.58M shares 10-Q · filed 2023-05-10 | ||||||
| 2022-12-31 | 5.03M shares 10-K · filed 2023-03-29 | ||||||
| 2022-09-30 | 5.28M shares 10-Q · filed 2022-11-10 | 5.28M shares 10-Q · filed 2022-11-10 | |||||
| 2022-06-30 | 5.61M shares 10-Q · filed 2022-08-10 | 5.61M shares 10-Q · filed 2022-08-10 | |||||
| 2022-03-31 | 5.43M shares 10-Q · filed 2023-05-10 | ||||||
| 2021-12-31 | 4.77M shares 10-K · filed 2023-03-29 | ||||||
| 2021-09-30 | 4.82M shares 10-Q · filed 2022-11-10 | 4.82M shares 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | 4.80M shares 10-Q · filed 2022-08-10 | 4.80M shares 10-Q · filed 2022-08-10 | |||||
| 2021-03-31 | 5.32M shares 10-Q · filed 2022-05-12 | ||||||
| 2020-12-31 | 4.64M shares 10-K · filed 2022-03-29 | ||||||
| 2020-09-30 | 4.65M shares 10-Q · filed 2021-11-10 | 4.65M shares 10-Q · filed 2021-11-10 | |||||
| 2020-06-30 | 4.65M shares 10-Q · filed 2021-08-12 | 4.65M shares 10-Q · filed 2021-08-12 | |||||
| 2020-03-31 | 4.66M shares 10-Q · filed 2021-05-13 | ||||||
| 2019-12-31 | 3.86M shares 10-K · filed 2021-03-30 | ||||||
| 2019-09-30 | 4.01M shares 10-Q · filed 2020-11-12 | 4.01M shares 10-Q · filed 2020-11-12 | 3.41M shares 10-Q · filed 2019-11-13 | ||||
| 2019-06-30 | 4.11M shares 10-Q · filed 2020-08-13 | 4.11M shares 10-Q · filed 2020-08-13 | 3.44M shares 10-Q · filed 2019-08-13 | ||||
| 2019-03-31 | 4.54M shares 10-Q · filed 2020-05-14 | ||||||
| 2018-12-31 | 3.55M shares 10-K · filed 2020-03-30 | ||||||
| 2018-09-30 | 4.01M shares 10-Q · filed 2019-11-13 | 3.41M shares 10-Q · filed 2019-11-13 | |||||
| 2018-06-30 | 4.11M shares 10-Q · filed 2019-08-13 | 3.44M shares 10-Q · filed 2019-08-13 | |||||
| 2018-03-31 | 3.44M shares 10-Q · filed 2019-05-09 | ||||||
| 2017-12-31 | 2.71M shares 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |